| |
1 2 3 4 5 6 7 8 9
| | locus | group | % |
|---|
LVQGQ GI | IQPQ QPAQ L | EVIR SLVLGTLPTMCN |
Gli-A1
| 6 | 19 |
LVQGQ GI | IQPQ QPAQ Y | EVIR SLVLR TLPNMCN |
Gli-A1
| 7 | 5 |
LVQGQ GI | IQPQ QPAQ L | EVIR SLVLR TLPTMCN |
Gli-B1
| 3 | 6 |
LVQGQ GI | IQPQ QLAQL | EAIR SLVLQTLPTMCN |
Gli-B1
| 8 | 3 |
LAQGLGI | IQPQ QPAQL | EGIR SLVLK TLPTMCN |
Gli-B1
| 5 | 17 |
LVQGQ GI | IQPQ QPAQL | EAIR SLVLQTLPSMCN |
Gli-D1
| 9 | 41 |
LVQGQ GI | IQPQ QPAQL | EAIR SLVLQTLPTMCN |
Gli-D1
| 10 | 9 |
- Natural variants of γ-II (glia-γ30; IQPQ QPAQ) epitope in expressed γ-gliadins of T.aestivum. This epitope is located in the C-terminal part of γ-gliadins (domain V). % = fraction of total number of γ-gliadins transcripts. Glutamine residues that are a primary targets for the enzyme tissue transglutaminase are to depicted in bold (Q) in QxP target sites whereas moderate target sites are depicted in italics, (Q) [13, 14]. Cleavage sites: R, K in bold, trypsin; cleavage occurs at the right side (C-terminal direction) of the marked amino acid.
